Xtandi 00469-1725
Generic: Enzalutamide
Product NDC
00469-1725- Manufacturer
- Astellas Pharma Us, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 4, 2020
- Listing Expires
- December 31, 2026
- Application
- NDA213674
Need to source Xtandi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Enzalutamide | 40 mg/1 |
Drug Class
Androgen Receptor Inhibitor [EPC]Androgen Receptor Antagonists [MoA]Androgen Receptor Inhibitor [EPC]
Packaging Options(1)
1 BOTTLE in 1 CARTON (0469-1725-56) / 56 TABLET in 1 BOTTLE